clopidogrel and Cytokine Release Syndrome

clopidogrel has been researched along with Cytokine Release Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anil Kumar, S; Othman, M; Tafazoli, A	1

Reviews

1 review(s) available for clopidogrel and Cytokine Release Syndrome

Article	Year
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications. Platelets, 2022, Jan-02, Volume: 33, Issue:1 Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Fibrinolytic Agents; Humans; Lung; Platelet Activation; Pulmonary Embolism; SARS-CoV-2; Treatment Outcome	2022

Article

Year

Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.

Platelets, 2022, Jan-02, Volume: 33, Issue:1

Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Fibrinolytic Agents; Humans; Lung; Platelet Activation; Pulmonary Embolism; SARS-CoV-2; Treatment Outcome

2022